Delivery Order V797D70255-36C24526N0594

The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5) awarded a delivery order valued at $31,800 to Galderma Laboratories, L.P. for the supply of Nemluvio 30 mg, an injectable pharmaceutical product. The contract was awarded on March 18, 2026, with an ultimate completion date of March 20, 2026, reflecting the time-sensitive nature of pharmaceutical supply to VA healthcare operations. This delivery order operates under a firm fixed-price arrangement with no...

The Department of Veterans Affairs, Veterans Integrated Service Network 5 (VISN 5), awarded a delivery order to Galderma Laboratories, L.P. on April 15, 2026, for the supply of Nemluvio 30 mg injectable pharmaceutical product. This firm fixed-price delivery order carries a ceiling value of $42.4K with an ultimate completion date of April 17, 2026, reflecting the time-sensitive nature of pharmaceutical supply to VA patient care operations. The contract was issued under the Pharmaceuticals and...

This delivery order awards $31.8K to Galderma Laboratories, L.P. for the supply of Nemluvio 30 mg, an injectable pharmaceutical product, under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The contract is funded by Veterans Integrated Service Network 5 (VISN 5), a civilian component of the Department of Veterans Affairs, with performance occurring in Carrollton, Texas. The award employs a firm fixed-price structure with no set-aside designation and an ultimate completion...

Galderma Laboratories, L.P., a foreign-owned pharmaceutical manufacturer based in Dallas, Texas, received a $31.8K delivery order from Veterans Integrated Service Network 5 (VISN 5) for NEMLUVIO 30 mg. The contract, awarded on December 2, 2025, with a completion date of December 3, 2025, represents a firm fixed-price arrangement with no set-aside designation. This delivery order falls under the broader Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) managed by the General...

Galderma Laboratories, L.P. was awarded a delivery order valued at $46,697.40 by Veterans Integrated Service Network 5 (VISN 5), a civilian agency within the Department of Veterans Affairs, for the supply of NEMLUVIO 30 mg pharmaceutical product. The contract, awarded on September 19, 2025, with an ultimate completion date of September 23, 2025, operates under a firm fixed-price arrangement with no set-aside designation. The delivery order was placed through the Pharmaceuticals and Drugs Federal...

Galderma Laboratories, L.P., a pharmaceutical manufacturer headquartered in Dallas, Texas, was awarded a delivery order on October 30, 2025, to supply 16 units of Nemolizumab 30mg injectable pens to the Department of Veterans Affairs' Veterans Integrated Service Network 21 (VISN 21). This contract, valued at $33,920, operates under a firm fixed-price arrangement with no set-aside designation and an ultimate completion date of February 6, 2026. The delivery order falls under the Pharmaceuticals...

This is a delivery order awarded by the Department of Veterans Affairs' Veterans Integrated Service Network 9 (VISN 9) to Galderma Laboratories, L.P., a foreign-owned, for-profit pharmaceutical manufacturer. The $12,314.40 fixed-price contract is for the emergency order of NEMOLIZUMAB CCP 30MG INJ, a specialized injectable medication. The contract was awarded under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) and has an ultimate completion date of April 10, 2025. There is no...

The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 18, 2026, with a ceiling value of $4,066.16 for Nemluvio 30 mg pens. Place of performance is Conshohocken, PA. The order was issued under the parent Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2031, which supplies pharmaceutical products and medical supplies to support military healthcare programs globally. Ultimate completion date is...

<p>The Defense Logistics Agency issued a $2,033.08 delivery order to AmerisourceBergen Drug Corp on March 5, 2026, for Nemluvio 30 mg pens, with ultimate completion by March 26, 2026.</p> <p>The order is issued under the company's Indefinite Delivery Contract with DLA Troop Support Medical, a $999,999,999 global pharmaceutical supply vehicle running through December 2026. Place of performance is Conshohocken, PA. The order carries firm fixed pricing and no set-aside.</p>

<p>The Defense Logistics Agency issued a delivery order to AmerisourceBergen Drug Corp on February 5, 2026, for Nemluvio 30 mg pens, with a ceiling value of $2,033.08.</p> <p>Place of performance is Conshohocken, PA 19428. Ultimate completion date is February 27, 2026. The order carries firm fixed-price pricing and was issued on a non-set-aside basis.</p>